Earnings Preview: CSTL to Report Financial Results Post-market on November 04

Moomoo NewsOct 29 21:00 ET

Castle Biosciences Presents Award-Winning Abstract at ACG 2024 Demonstrating Ability of Its TissueCypher Test to Significantly Reduce Healthcare Costs Associated With the Management of Barrett's Esophagus Patients

BusinesswireOct 29 16:30 ET

The Analyst Landscape: 4 Takes On Castle Biosciences

BenzingaOct 29 11:00 ET

Castle Biosciences Is Maintained at Buy by Canaccord Genuity

Dow JonesOct 29 08:29 ET · Ratings

CCORF Maintains Castle Biosciences(CSTL.US) With Buy Rating, Raises Target Price to $42

Moomoo NewsOct 29 07:31 ET · Ratings

Express News | Castle Biosciences Inc : Canaccord Genuity Raises Target Price to $42 From $35

ReutersOct 29 00:49 ET